Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Placed an order for 273 shares. ????
FALSE!!
They added. From 2.1M to 2.7 M
https://fintel.io/so/us/avxl
Including:
Morgan Stanley increasing by 68% 59K to 101K shares
Park West by 28%
2.1M shares to 2.7M shares
Hey but then again, according to some, they are ALL selling.
Not to shabby slowly moving up in insty holdings. Now just about reaching 24%.
Lol great clueless post. ENTIRE post is opinion rather than fact.
Lol earnings?
3 things can happen with this investment.
1. Anavex allows themselves to get bought out WHEN the time comes. Giving up a-273 and batting clean-up, A-371.
2. A-273 doesn’t pan out in all 3 trials and pps drops to pennies.
3. Anavex goes it alone to become the new BP on the block with a-273 in pocket and a-371 on the side waiting for its turn to prove itself.
Of course there are no earnings, that was settled many years ago.
You DO understand that the ride to $14 was a pump by nefarious people right, followed by the dump and attacks by ahh.. that was so long ago and not even worth reliving anymore, so are all the speculative talk.
Im here to see data readout and go from there, no matter how long it takes.
Wow, the sudden 180. Maybe he has no choice but to wait for the new guidance to come out. Does the delays suck? Yes.
How I’ll laugh when things start rolling and the 180 attitude again .
In the mean time, Missling said this to one of the questions.
Christopher Missling
Yes, all of these things we are – we have found something and we have submitted the analysis, the outcome of this to a very – the most reputable scientific meeting this year. And before that, we obviously are bind by the requirement to be silent on that until that will be disclosed exclusively at this conference.
You have the option to leave, no one is forcing you to stay invested, if one is even holding any stock.
I mined crypto in 2013, before mainstream even heard of it. Keeping everything I mined. Fast forward to today, it was a wise strategy.
Everyone has their own exit plan on Avxl. Mine happens to be many times the current pps or bad data from trials. Day to day drops are of no concern to me.
The best attack is Missling isn’t moving fast enough?, please.,,., there are real scam stocks out there, AVXL just happens to be not one of them, yet.
Wow, when did Dr. Missling start to be blamed for everyone’s losses in investing. It’s the investor that decides to stay or go. Don’t believe, leave. I remember Avxl and CBIO was at the same conference last year and about the same pps(under $5). Look at the difference now that CBIO is getting ready to release data. It shows the potential AVXL has when that time comes. Until then, adding little by little at these low prices. At least I have to thank the short and slanderers for that.
Cancer is the reference, but it should also apply for other diseases as well.
What do we do when we have a targeted drug, introduced in a properly selected group of patients, which has an outsized effect on overall survival in a rare or deadly cancer, but where that benefit is seen in a small trial, where we would still need more evidence to fully understand how to best use the drug in clinical practice?
We might want to approve such a product earlier, and require a post-market confirmatory study to validate the finding – similar to an accelerated approval approach.
Am I the only one that read the statement from today where it stated that approval would be given early under certain conditions and data will still need to be gathered AFTER? I'll look for the exact paragraphs. Saw it earlier today but had no time to post.
What make you of the Nov 30 FDA update on the progress of 21 century cures act? Ain't it 10am eastern tomorrow?
Too funny. That 6? That's 6 more than what BP could do in a thousand plus patient trial.....combined.
Then again, misdiagnosis is the counter these days.
I believe he isn't grappling with the data. He knows the design already and just waiting for FDA to give the nod.
Don't believe it? Guess we have a little over a month left before end of year arrives.
Yes, and with safety a non issue, it has a possibility of being one.
Very exciting idea during these manipulative times
How is it that 6 people could be misdiagnosed in a 32 patient trial yet in a 2000-3000 patient trial, not one?
Happen to have anything on misdiagnosed patients and how often they get placed in any Alz trial?
Remind me what that reality is on this great Thanksgiving Day?
So I checked the instys that filed looking if any new ones got added since 11/15. Low and behold, SIG reported on 11/15 that all put, call, and about 260,000 shares were exited during the last quarter. Then on the 20th, it went from all exited to all 3 positions being reduced. So, now we are back to over 10 Million shares held by instys.
How often does that happen?
Read one comment behind. Lt is calling the pr fluff even though it's a pr about being reviewed by other professionals in their respective fields.
Peer review is fluff now? Lol
I think we are all aware of the prestigious people who dropped out of college and created their own empire most college grads would dream of.
DD is good ONLY if it's done correctly. Doing a background, worse, college one on someone that has been in the FDA for over 20 years has NO meaning. You might think it does, but most know what's going on. Nothing but a sideshow trying to gain attention.
Now if you were to do some DD on a-273, I'd be all ears.
Well, I'm sure you'll start seeing the name a lot more in the coming years
Oh no, even IF trials run behind schedule for some unknown reason, I will still be here. Missling and EVERYONE below him is top notch in their respective field
Pharma investing is a tricky thing
"So he does have right information but does not share it to protect from shorts? How many times I have heard this excuse being used on boards"
I never said that. What I did say was that he is keeping data not only from shareholders BUT ALSO the shorts and BP that could very well possibly be waiting on more data.
Thanks for trying to understand a simple paragraph though.
He stated multiple times trials start by end of year. Last time I checked there's still a whole December before the year ends.
Never understand the logic in investing in a company where one doesn't believe in the CEO and board to get things done.
If I ever feel like Missling is lying to ME, I'll quietly exit my position. No need to yell it on a board or seem like a sour investor that lost money.
I'd gladly bring up your conversational banter in exactly 365 days from today just to see where we stand then compared to today.
I know, you were around just as long as I.
He's not only hiding information from company shareholders, he's also hiding info from the short cabal as well as the sharks that are circling the company waiting to aggressively takeover the co. Believe it or not, it does happen.
As long a Missling continues to implement his plan for the company, and data remains positive, time is on our, the longs, side.
Now is not the time to grow impatient just when the "iceburg" is about to set sail.
Then again, everyone has their own opinion.
I suspect you didn't think they were transparent 2 years ago when they pr'd a lot more and even was called a pr scam machine. Damned if they do damned if they don't.
Either way, science WILL put the pps in its correct spot eventually no matter if they communicate with impatient shareholders that don't understand what by end of year means.
Whats the chances of A-273 being designated Regenerative Medicine Advanced Therapy Designation (RMAT)?
Interesting that it states the following:
"The request for RMAT designation must be made either concurrently with submission of an Investigational New Drug application (IND) or as an amendment to an existing IND. We will not grant a RMAT designation if an IND is on hold or is placed on hold during the designation review."
then:
"To be clear, we remain committed to ensuring that patients have access to safe and effective regenerative medicine products as efficiently as possible."
I don't care what the pps right now, things are starting to warm up behind the scenes.
Meager? With everyone on different doses and still finding positives within the entire group?
Wait till p2/3 and if results are the same, then its meager.
Still would be better than soc though. Which would still get approved if that happened.
Seems like a perfect phrase to use.
cautiously optimistic:
hopeful about something, but recognizing the problems involved
vivek ramaswamy already took that spot.
Isn't that just about 12 months?
ok, maybe 13, but no where near the 3 years as being pushed around by some nefarious people.
In Bill Gates own words:
"There are many ways an Alzheimer’s drug might help prevent or slow down the disease. Most drug trials to date have targeted amyloid and tau, two proteins that cause plaques and tangles in the brain. I hope those approaches succeed, but we need to back scientists with different, less mainstream ideas in case they don’t. A more diverse drug pipeline increases our odds of discovering a breakthrough."
Missling himself said around 300 patients so that point is moot debating.
Revamping the FDA guidelines helps speed up the process of getting access of said drug to patient, as long as it is safe. So again, 2-3 years is a bit far fetched. Especially with 25 patients already in the 2-3 year realm and still providing useful data. So the p2a/b continuing data along with the p2/3 at even 1 year would get the longs here across the finish line.
With Axon, NTRP, BIIB and every other BP failing to provide a better than soc treatment for Alz, it's taking the little pharmas to lead the charge and discover new possibilities only to then get bought out by BP. Now, do you REALLY think BIIB didn't try and buy Anavex on the cheap?
Ill dare to guess that come next friday, insties will have a larger position than 24%
I believe he stated Partnership "WHEN THE TIME COMES".
Anavex, the company, is worth more today with 3rd party research proving it could benefit multiple cns diseases.
pps is just smoke and mirrors trying to incite panic selling.
% of shares held by Instys, if higher than 24%, will also prove shorts are full of fud.